Headquartered in Vancouver, Canada, with business expanded to international cities such as Seattle, US and Beijing, China, Cacnex specializes in acquisition and licensing services across North America and China.

 

Our expertise spans high-value, non-public tangible assets, as well as intellectual property transfers through strategic licensing and partnership agreements mainly in the field of healthcare, catering to enterprises and investors seeking cross-border opportunities. 

 

With China’s recent medical reforms accelerating global expansion and R&D in biotech, Cacnex helps drive IP commercialization in this dynamic market.

 

Leveraging our team’s deep industry knowledge and extensive networks across major biotech hubs in the U.S. and Canada, we offer comprehensive, end-to-end licensing solutions — from sourcing IP to realizing its market value. 

 

To date, Cacnex has forged relationships with over 100 leading biopharmaceutical and biotech firms in North America, spanning clusters in Seattle, Silicon Valley, San Diego, Boston, and Vancouver.

 

Our team analyzes each partner’s key technologies and product pipelines to identify promising collaboration opportunities that align with the rapid growth of China’s healthcare sector.